U.S. development Phase success rates for oncology and non oncology drugs 2011-2020
This statistic shows the probability of success for new oncology and non-oncology drugs in the U.S. through the various stages of development, from January 1, 2011, to November 30, 2020. It was found that while the probability that a new non-oncology drug makes it from phase I to approval was 9.3 percent, it was only 5.3 percent for oncology drugs.
